Prestige Consumer Healthcare (PBH) EBITDA Margin Growth (3y) (2013 - 2025)
Prestige Consumer Healthcare (PBH) EBITDA Margin Growth (3y) (2013 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 1,129.00 |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 2.00 |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 59.00 |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | -1,031.00 |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -925.00 |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | -46.00 |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 6,666.00 |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Prestige Consumer Healthcare | 2.42 Bn | 2.36 Bn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -254.00 |
| Sep 30, 2025 | -11.00 |
| Jun 30, 2025 | -265.00 |
| Mar 31, 2025 | 82.00 |
| Dec 31, 2024 | 158.00 |
| Sep 30, 2024 | 128.00 |
| Jun 30, 2024 | -696.00 |
| Mar 31, 2024 | -18.00 |
| Dec 31, 2023 | -5.00 |
| Sep 30, 2023 | 12.00 |
| Jun 30, 2023 | -442.00 |
| Mar 31, 2023 | -12,772.00 |
| Dec 31, 2022 | 1.00 |
| Sep 30, 2022 | 4.00 |
| Jun 30, 2022 | 61.00 |
| Mar 31, 2022 | 9,267.00 |
| Dec 31, 2021 | -203.00 |
| Sep 30, 2021 | -119.00 |
| Jun 30, 2021 | 539.00 |
| Mar 31, 2021 | 3,886.00 |